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Following publication of the original article in Stem
Cell Research & Therapy [1], we would like to alert the
reader that the immune-histological sections shown in
Fig. 2 bottom line are mistakenly the images from an
experiment using a different Tie2+ antibody than origin-
ally reported in the manuscript (i.e. R&D, anti-human
Tie2 labeled APC, cat.No:FAB3131A, clone:83715,
mouse IgG) for the florescence associated cell sorting
(FACS). This antibody has been previously tested in the
group of Prof. Dr. Daisuke Sakai and was performed by
Ms Tomoko Nakai, Tokai University. This antibody,
however, was not found to be specific for bovine Tie2+
cells. The immune-histology procedure was correctly de-
scribed using the PG antibody from Millipore. However,
the pictures presented in Fig. 2 in the last raw in the
article of Tekari et al. [1] are not from the same experi-
ment using the Tie2 antibody from Bioss, inc. clone
bs-1300R, Bioss Antibodies, Woburn, MA, USA, as the
publication reported.
We have now fixed this issue by providing a new Fig. 2
using the reported Tie2 primary antibody from Bioss
and the secondary antibody labeled with Alexa 488
(cat# A-11008, Molecular Probes, Life Technologies, Zug,
Switzerland) for FACS sorting.
The corrected Material and Methods Section for this
part on page 4 of the original article should read:
“Immunohistochemical staining for proteoglycans was
performed by incubation of the sections with a
monoclonal mouse anti-human proteoglycan antibody
(10 μg/ml, clone EFG-4; Millipore, Billerica, MA, USA, di-
luted 1:50) overnight at 4 °C after permeabilization with
100 % methanol for 2 min, rehydration and blocking with
10 % FBS in phosphate buffered saline (PBS) for 1 hour.
Secondary antibody was then added after stringent
washing for 1 hour on the next day, which was a goat
anti-mouse antibody (Alexa Fluor 555 goat anti-mouse
SFX-Kit IgG A-31621, Invitrogen, Fisher-Scientific, Basel,
1:200 diluted). Finally, slides were mounted in DAPI con-
taining embedding medium (Fluoroshield™ cat# ab104139,
abcam plc, Cambridge, UK). Images were then taken with
a confocal laser scanning microscope at a 10x magnifica-
tion and using 4x4 tile imaging (cLSM710, Carl Zeiss,
Jena, Germany).”
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Fig. 2 Osteogenic, adipogenic and chondrogenic differentiation assays. a The differentiation assays were performed in Tie2-, Tie2+ (i.e. NPPC)
cells after sorting and a mixed cell population (unsorted NPC). Top panel represents the macroscopic and microscopic images of osteogenesis
(Alizarin red staining). Middle panel represents the adipogenic differentiation (Oil red O staining), and arrows highlight the formation of fat droplets.
Lower panel represents the chondrogenic differentiation: Safranin-O staining and proteoglycans (PG, red) immunohistochemistry counterstained with
DAPI (4',6-diamidino-2-phenylindole, blue). Results of one representative experiment of at least 3 repeats are shown. Scale bars are indicated on the
images. b Quantification of Alizarin red staining (ARS), Oil red O fat droplets positive cells and GAG/DNA content. Individual cell populations were
cross-compared to determine significance with *p < 0.05. Bars represent mean ± SD (N=5)
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